At a glance
ClinicalIndex Comparison RecordN/ACompleted· 522 enrolled
Drug / intervention
Adaptive CRT (aCRT) +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Adaptive Cardiac Resynchronization Therapy Study
In Brief
A clinical study evaluating Adaptive CRT (aCRT) and Echo for Heart Failure. Completed, enrolled 522 participants across 105 sites in 19 countries.
Detailed Summary
The purpose of this study is to demonstrate the AdaptivCRT algorithm is at least as good as manual echo based optimization in regard to patient outcomes and cardiac performance
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure
CountriesAustralia, Austria, Belgium, Canada, Denmark, Germany, Greece, Hong Kong, Hungary, Italy, Japan, Netherlands, Norway, Russia, Saudi Arabia, Serbia, Spain, Sweden, United States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 2009
Enrollment StartOct 2009
Primary CompletionAug 2011
Study CompletionMar 2012
TodayJul 2026
First PostedSep 18, 2009
Enrollment StartOct 1, 2009
Primary CompletionAug 4, 2011
Study CompletionMar 8, 2012
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 16.8 years ago
Interventions
Adaptive CRT (aCRT)device
Adaptive CRT (aCRT) is an algorithm, which provides ambulatory adjustment of pacing configuration (LV-only or BiV) and AV and VV delays based on periodic automatic evaluation of electrical conduction to optimize cardiac function
Echodevice
Standard BiV pacing with settings optimized using a standardized echocardiographic protocol